Tauriga Sciences, a life sciences company building a portfolio of medical technologies, has publicly launched Constellation Diagnostics Inc., a developer of a camera-based technology designed to prevent skin cancer through early detection.
Constellation’s imaging-based diagnostic enables patients to quickly conduct full body scans in their homes, in health clubs, doctors’ offices or other commercial settings.
“Constellation’s novel imaging system has relevance to millions of people worldwide who are at risk for skin cancer. Skin cancer is the most common of all cancers and represents nearly half of all cancers in the United States,” Tauriga COO Dr. Stella Sung stated in the press release. “We are excited about the potential of this dermatologist-endorsed product to save many lives through comprehensive and early tracking and detection.”
Constellation CEO Christian Bailey added, “Computer Vision has already revolutionized other industries. The vision systems that Constellation builds on are much like the ones that proved effective in sending a driverless car coast-to-coast, which we expect will allow us to demonstrate a product within one year.”
Per a previously announced Memorandum of Understanding, Taurigacan earn an equity stake in Constellation of up to a 35 percent; and as previously disclosed, Tauriga has made an initial investment.
For more information visit www.taurigasciences.com or www.constellationcare.com
Let us hear your thoughts below: